SeaCrest Wealth Management’s Impax Laboratories, Inc. IPXL Stock Holding History

SeaCrest Wealth Management’s Portfolio IPXL Stock Details IPXL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q2	–	Sell	-300	Closed	-$6K	–	2365
2018 Q1	$6K	Hold	300	–	–	﹤0.01%	1766
2017 Q4	$5K	Buy	+300	New	+$5.5K	﹤0.01%	1837

SeaCrest Wealth Management's IPXL Position: Q2 2018 in Review

SeaCrest Wealth Management sold out of Impax Laboratories, Inc. (IPXL) in Q2 2018, closing a stake of 300 shares — an estimated $6K sold.

SeaCrest Wealth Management first reported a position in IPXL in Q4 2017 and held it in 2 quarters. The position peaked at $6K in Q1 2018. 1 fund tracked by Wall St. Rank holds IPXL as of Q2 2018.

SeaCrest Wealth Management reported no remaining Impax Laboratories, Inc. position as of Q2 2018 after selling out during the quarter.
SeaCrest Wealth Management sold 300 Impax Laboratories, Inc. shares in Q2 2018, an estimated $6K.
SeaCrest Wealth Management first reported a position in Impax Laboratories, Inc. in Q4 2017 and held it in 2 quarters.
SeaCrest Wealth Management's Impax Laboratories, Inc. position peaked at $6K in Q1 2018.
1 fund tracked by Wall St. Rank held Impax Laboratories, Inc. as of Q2 2018.

Based on SeaCrest Wealth Management's 13F filing for Q2 2018, filed 3 Aug 2018.